SlideShare a Scribd company logo
Dr.S.Ramarajan M.D
Assistant Professor of Medicine
*
*
*Whether the hyperbilirubinemia is
predominantly conjugated or
unconjugated in nature.
*Whether other biochemical tests are
abnormal.
Production of
bilirubin
Hepatic/biliary
removal
*
Bilirubin in
serum
Hepatic/biliary
removal of the
pigment
Production of
bilirubin
*
*
*Hemolytic process resulting in
overproduction of bilirubin
(HEMOLYTIC DISORDERS &
INEFFECTIVE ERYTHROPOIESIS).
*Impaired uptake /conjugation of
bilirubin(DRUG EFFECT or GENETIC
DISORDERS)
*
1.Indirect hyperbilirubinemia
1. Hemolytic disorders
1. Inherited
1. Spherocytosis, elliptocytosis
2. Glucose-6-phosphate dehydrogenase and pyruvate kinase
deficiencies
3. Sickle cell anemia
2. Acquired
1. Microangiopathic hemolytic anemias
2. Paroxysmal nocturnal hemoglobinuria
3. Spur cell anemia
4. Immune hemolysis
5. Parasitic infections
1. Malaria
2. Babesiosis
2. Ineffective erythropoiesis
1. Cobalamin, folate, thalassemia, and severe iron deficiencies
3. Drugs
1. Rifampicin, probenecid, ribavirin
4. Inherited conditions
1. Crigler-Najjar types I and II
2. Gilbert's syndrome
CAUSES OF ISOLATED HYPERBILIRUBINEMIA
*
• Complete absence
of UDPGT activity
• Reduced UDPGT
activity
CRIGGLER
NAJAR
syndrome
type 1& 2
• Reduced UDPGT
activity
• Bilirubin 6mg/dL
GILBERT
syndrome
*
*
*Direct hyperbilirubinemia
*Inherited conditions
*Dubin-Johnson syndrome
*Rotor's syndrome
*
• Mutation in gene for
multiple drug
resistance protein 2
Dubin
johnson
syndrome
• Problem with
hepatic storage of
bilirubin
Rotor
syndrome
*
*History
*Physical examination
*Lab tests
*
*Drugs.
* H/o transfusions, intravenous and intranasal drug
use ,tattoos and sexual activity.
*H/o recent travel.
*H/o exposure to people with jaundice .
*H/o Exposure to contaminated foods.
*H/o Alcohol consumption.
*H/o myalgia , arthralgia ,rash.
*Anorexia , weight loss
*Abdominal pain
*Fever
*Pruritus
*Changes in urine and stool colour.
*
*Arthralgia and myalgia precluding jaundice-
HEPATITIS(viral or drug related).
*Jaundice associated with sudden onset of
severe RUQ pain and chills –
CHOLEDOCHOLITHIASIS AND ASCENDING
CHOLANGITIS.
*
*Temporal and Proximal muscle wasting – cirrhosis or
pancreatic cancer.
*Features of Chronic liver disease.
*VIRCHOW’S NODE.
*Sister Mary Joseph’s nodule.
*ELEVATED JVP, ASCITES, RIGHT PLEURAL EFFUSION -
CONGESTION
*
*Enlarged left lobe of liver – cirrhosis.
*Nodular liver or abdominal mass- malignancy.
*Enlarged tender liver- hepatitis viral or alcoholic , acutely
congested liver.
*Murphy’s sign- cholecystitis.
*Ascites + jaundice – cirrhosis or malignancy.
*
*Patients with hepatocellular process-
aminotransferases elevation
disproportionate to ALP.
*Patients with a cholestatic process have
disproportionate elevation of ALP compared to
aminotransferases.
*SERUM ALBUMIN – A low serum albumin suggests
a chronic process such as cirrhosis or cancer.
*PROTHROMBIN TIME – elevated PT indicates
either vitamin K deficiency due to prolonged
jaundice or malabsorption or significant
hepatocellular dysfunction.
Viral hepatitis
• Hepatitis A, B, C, D, and E
• Epstein-Barr virus
• Cytomegalovirus
• Herpes simplex
Alcohol
Drug toxicity
• Predictable, dose-dependent, (e.g., acetaminophen)
• Unpredictable, idiosyncratic, (e.g., isoniazid)
Environmental toxins
• Vinyl chloride
• Jamaica bush tea—pyrrolizidine alkaloids
• Kava Kava
• Wild mushrooms—Amanita phalloides or A. verna
Wilson's disease
Autoimmune hepatitis
HEPATOCELLULAR CONDITIONS THAT MAY PRODUCE JAUNDICE
*
Viral hepatitis Alcohol DRUGS
TOXINS
Wilson’s
disease/Autoimmune
Hepatitis
*
*Patients with alcoholic hepatitis will have AST :ALT
ratio of 2:1
*AST rarely exceeds 300 U/L.
*Patients with hepatitis due to viral or toxin-related
will have Aminotransferases > 500 U/L.
*
*IgM HAV.
*Hbs Ag.
*IgM anti Hbc.
*HCV RNA.
*Tests for EBV,CMV.
*Wilson’s disease do Serum Ceruloplasmin level.
*Autoimmune hepatitis – ANA and specific immunoglobulins.
*
*Intrahepatic
*Extrahepatic
*Do an USG that will detect the presence of biliary dilatation.
*Biliary dilatation + = extrahepatic cholestasis
*Biliary dilatation - = intrahepatic cholestasis
*
• Intrahepatic cholestasis
• Primary biliary cirrhosis
• Primary sclerosing
cholangitis
Extra hepatic
cholestasis
• Benign
• Malignant
1.Intrahepatic
1. Viral hepatitis
1.Fibrosing cholestatic hepatitis—hepatitis B and C
2.Hepatitis A, Epstein-Barr virus, cytomegalovirus
2. Alcoholic hepatitis
3. Drug toxicity
1.Pure cholestasis—anabolic and contraceptive steroids
2.Cholestatic hepatitis—chlorpromazine, erythromycin
estolate
3.Chronic cholestasis—chlorpromazine and
prochlorperazine
4. Primary biliary cirrhosis
5. Primary sclerosing cholangitis
6. Vanishing bile duct syndrome
1.Chronic rejection of liver transplants
2.Sarcoidosis
3.Drugs
CHOLESTATIC CONDITIONS THAT MAY PRODUCE JAUNDICE
1.Inherited
1.Progressive familial intrahepatic cholestasis
2.Benign recurrent cholestasis
2.Cholestasis of pregnancy
3.Total parenteral nutrition
4.Nonhepatobiliary sepsis
5.Benign postoperative cholestasis
6.Paraneoplastic syndrome
7.Venoocclusive disease
8.Graft-versus-host disease
9.Infiltrative disease
1.TB
2.Lymphoma
3.Amyloidosis
*
*Hepatitis B, Hepatitis C can cause a cholestatic hepatitis.
*Hepatitis A , CMV, EBV, alcoholic hepatitis can also produce
cholestatic picture.
*Primary biliary cirrhosis –Antimitochondrial antibody.
*Primary sclerosing cholangitis- multiple strictures of bile
ducts with dilatation proximal to strictures.
*
*Distal CBD is an area that is difficult to be
visualized by USG.
*CT scan .
*MRCP (Magnetic resonance cholangiography).
*ERCP(Endoscopic Retrograde Cholangio Pancreatography).
*
*Benign and malignant cause.
*Malignant causes include Pancreatic,
Gall bladder , Ampullary and
cholangiocarcinoma.
*Extrahepatic
*Malignant
*Cholangiocarcinoma
*Pancreatic cancer
*Gallbladder cancer
*Ampullary cancer
*Malignant involvement of the porta hepatis lymph nodes
*Benign
*Choledocholithiasis
*Postoperative biliary structures
*Primary sclerosing cholangitis
*Chronic pancreatitis
*AIDS cholangiopathy
*Mirizzi syndrome
*Parasitic disease (ascariasis)
*
SUMMARY
Unconjugated
hyperbilirubinemia
Conjugated
hyperbilirubinemia
*
*
Dubin Johnson syndrome
Rotor syndrome
*
Viral hepatitis Alcohol
DRUGS TOXINS
Wilson’s
disease/Autoimmune
Hepatitis
*
• Intrahepatic cholestasis
• Primary biliary cirrhosis
• Primary sclerosing
cholangitis
Extra hepatic
cholestasis
• Benign
• Malignant
*
*Total bilirubin- 6.3mg/dl.
*Direct bilirubin – 3.9 mg/dl.
*Indirect bilirubin- 2.4 mg/dl.
*SGOT – 292 U/L.
*SGPT – 542 U/L.
*ALP – 60 U/L.
*TOTAL PROTEIN – 5.6 gm/dl.
*Albumin – 3.7 gm/dl.
*Globulin 1.9 gm/dl.
*A/G ratio 1.9:1
Approach to a patient with jaundice

More Related Content

What's hot

Wilson disease with acute liver failure case presentation
Wilson disease with acute liver failure case presentationWilson disease with acute liver failure case presentation
Wilson disease with acute liver failure case presentation
Sanjeev Kumar
 

What's hot (20)

Autoimmune hepatitis rajesh
Autoimmune hepatitis rajeshAutoimmune hepatitis rajesh
Autoimmune hepatitis rajesh
 
03.06.09: Spontaneous Hypoglycemia
03.06.09: Spontaneous Hypoglycemia03.06.09: Spontaneous Hypoglycemia
03.06.09: Spontaneous Hypoglycemia
 
Approach to jaundice
Approach to jaundiceApproach to jaundice
Approach to jaundice
 
Acute & chronic liver failure
Acute & chronic liver failureAcute & chronic liver failure
Acute & chronic liver failure
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
Approach to jaundice
Approach to jaundiceApproach to jaundice
Approach to jaundice
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
autoimmune hepatitis
 autoimmune hepatitis autoimmune hepatitis
autoimmune hepatitis
 
Hepatic encephalopathy for student by dr Mohammed Hussien
Hepatic encephalopathy for student by dr Mohammed Hussien Hepatic encephalopathy for student by dr Mohammed Hussien
Hepatic encephalopathy for student by dr Mohammed Hussien
 
Lupus nephritis 2016
Lupus nephritis 2016Lupus nephritis 2016
Lupus nephritis 2016
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
 
Approach to CKD
Approach to CKDApproach to CKD
Approach to CKD
 
Hepatic Encephalopathy
Hepatic EncephalopathyHepatic Encephalopathy
Hepatic Encephalopathy
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Wilson disease with acute liver failure case presentation
Wilson disease with acute liver failure case presentationWilson disease with acute liver failure case presentation
Wilson disease with acute liver failure case presentation
 
Cirrhosis and Its Complications
Cirrhosis and Its ComplicationsCirrhosis and Its Complications
Cirrhosis and Its Complications
 
Approach to a patient with jaundice
Approach to a patient with jaundiceApproach to a patient with jaundice
Approach to a patient with jaundice
 
Primary hyperaldosteronism
Primary hyperaldosteronismPrimary hyperaldosteronism
Primary hyperaldosteronism
 
Jaundice
JaundiceJaundice
Jaundice
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 

Viewers also liked

Jaundice presentation
Jaundice presentationJaundice presentation
Jaundice presentation
mbishara
 
All about Jaundice
All about JaundiceAll about Jaundice
All about Jaundice
ozhin araz
 
Pt assess history taking
Pt assess   history takingPt assess   history taking
Pt assess history taking
Ben Lesold
 
Approach to cholestasis
Approach to cholestasisApproach to cholestasis
Approach to cholestasis
drsadhana86
 
An approach to a pt. with jaundice
An approach to a pt. with jaundiceAn approach to a pt. with jaundice
An approach to a pt. with jaundice
Amena Yasmin
 

Viewers also liked (18)

Jaundice presentation
Jaundice presentationJaundice presentation
Jaundice presentation
 
clinical approach to jaundice in adults
clinical approach to jaundice in adultsclinical approach to jaundice in adults
clinical approach to jaundice in adults
 
All about Jaundice
All about JaundiceAll about Jaundice
All about Jaundice
 
Pt assess history taking
Pt assess   history takingPt assess   history taking
Pt assess history taking
 
Jaundice
JaundiceJaundice
Jaundice
 
An approach to jaundice
An approach to jaundiceAn approach to jaundice
An approach to jaundice
 
Hepatology 101
Hepatology 101Hepatology 101
Hepatology 101
 
NNJ
NNJNNJ
NNJ
 
Approach to Anemia
Approach to Anemia Approach to Anemia
Approach to Anemia
 
Approach to cholestasis
Approach to cholestasisApproach to cholestasis
Approach to cholestasis
 
Jaundice
JaundiceJaundice
Jaundice
 
Investigations in jaundice
Investigations in jaundiceInvestigations in jaundice
Investigations in jaundice
 
Jaundice
JaundiceJaundice
Jaundice
 
Jaundice
JaundiceJaundice
Jaundice
 
Approach to anemia and jaundice
Approach to anemia and jaundiceApproach to anemia and jaundice
Approach to anemia and jaundice
 
An approach to a pt. with jaundice
An approach to a pt. with jaundiceAn approach to a pt. with jaundice
An approach to a pt. with jaundice
 
Approach to a child with jaundice
Approach to a child with jaundice Approach to a child with jaundice
Approach to a child with jaundice
 
Approach to cholestatic jaundice
Approach to cholestatic jaundiceApproach to cholestatic jaundice
Approach to cholestatic jaundice
 

Similar to Approach to a patient with jaundice

Liver diseases yakrut vikara
Liver diseases  yakrut vikaraLiver diseases  yakrut vikara
Liver diseases yakrut vikara
Prathamesh Karpe
 
clinicalapproachtojaundice-140123123013-phpapp01.pptx
clinicalapproachtojaundice-140123123013-phpapp01.pptxclinicalapproachtojaundice-140123123013-phpapp01.pptx
clinicalapproachtojaundice-140123123013-phpapp01.pptx
Vivek Ghosh
 
Liverdiseaseinpregnancy2 090429102624-phpapp01
Liverdiseaseinpregnancy2 090429102624-phpapp01Liverdiseaseinpregnancy2 090429102624-phpapp01
Liverdiseaseinpregnancy2 090429102624-phpapp01
DrHarsh Saxena
 

Similar to Approach to a patient with jaundice (20)

Approach to jaundice.pptx
Approach to jaundice.pptxApproach to jaundice.pptx
Approach to jaundice.pptx
 
Fulminant hepatic failure
Fulminant hepatic failureFulminant hepatic failure
Fulminant hepatic failure
 
Jaundice in pregnancy
Jaundice in pregnancyJaundice in pregnancy
Jaundice in pregnancy
 
0bstructive jaundice.pptx
0bstructive jaundice.pptx0bstructive jaundice.pptx
0bstructive jaundice.pptx
 
Liver transplant
Liver transplantLiver transplant
Liver transplant
 
Liver diseases yakrut vikara
Liver diseases  yakrut vikaraLiver diseases  yakrut vikara
Liver diseases yakrut vikara
 
Dr. Arun aggarwal Gastroenterologist : Acute Liver Failure
Dr. Arun aggarwal Gastroenterologist : Acute Liver FailureDr. Arun aggarwal Gastroenterologist : Acute Liver Failure
Dr. Arun aggarwal Gastroenterologist : Acute Liver Failure
 
Jaundice
JaundiceJaundice
Jaundice
 
clinicalapproachtojaundice-140123123013-phpapp01.pptx
clinicalapproachtojaundice-140123123013-phpapp01.pptxclinicalapproachtojaundice-140123123013-phpapp01.pptx
clinicalapproachtojaundice-140123123013-phpapp01.pptx
 
2-Approach-to-Elevated-LFT.ppt
2-Approach-to-Elevated-LFT.ppt2-Approach-to-Elevated-LFT.ppt
2-Approach-to-Elevated-LFT.ppt
 
ACUTE LIVER FAILURE - APPROACH AND MANAGEMENT
ACUTE LIVER FAILURE - APPROACH AND MANAGEMENTACUTE LIVER FAILURE - APPROACH AND MANAGEMENT
ACUTE LIVER FAILURE - APPROACH AND MANAGEMENT
 
Clinical Case on Jaundice
Clinical Case on JaundiceClinical Case on Jaundice
Clinical Case on Jaundice
 
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptxANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
 
Biochemical changes in liver diseases (2).pptx
Biochemical changes in liver diseases (2).pptxBiochemical changes in liver diseases (2).pptx
Biochemical changes in liver diseases (2).pptx
 
Evaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemiasEvaluation of liver function and hyperbilirubinemias
Evaluation of liver function and hyperbilirubinemias
 
hepatology for primary practitioners.pptx
hepatology for  primary practitioners.pptxhepatology for  primary practitioners.pptx
hepatology for primary practitioners.pptx
 
jaundice.pptx
jaundice.pptxjaundice.pptx
jaundice.pptx
 
JAUNDICE.pptx
JAUNDICE.pptxJAUNDICE.pptx
JAUNDICE.pptx
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 
Liverdiseaseinpregnancy2 090429102624-phpapp01
Liverdiseaseinpregnancy2 090429102624-phpapp01Liverdiseaseinpregnancy2 090429102624-phpapp01
Liverdiseaseinpregnancy2 090429102624-phpapp01
 

Recently uploaded

Recently uploaded (20)

Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
 
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
Vaccines: A Powerful and Cost-Effective Tool Protecting Americans Against Dis...
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 

Approach to a patient with jaundice

  • 2. * *Whether the hyperbilirubinemia is predominantly conjugated or unconjugated in nature. *Whether other biochemical tests are abnormal.
  • 3.
  • 5. * Bilirubin in serum Hepatic/biliary removal of the pigment Production of bilirubin
  • 6. *
  • 7.
  • 8. * *Hemolytic process resulting in overproduction of bilirubin (HEMOLYTIC DISORDERS & INEFFECTIVE ERYTHROPOIESIS). *Impaired uptake /conjugation of bilirubin(DRUG EFFECT or GENETIC DISORDERS)
  • 9. *
  • 10. 1.Indirect hyperbilirubinemia 1. Hemolytic disorders 1. Inherited 1. Spherocytosis, elliptocytosis 2. Glucose-6-phosphate dehydrogenase and pyruvate kinase deficiencies 3. Sickle cell anemia 2. Acquired 1. Microangiopathic hemolytic anemias 2. Paroxysmal nocturnal hemoglobinuria 3. Spur cell anemia 4. Immune hemolysis 5. Parasitic infections 1. Malaria 2. Babesiosis 2. Ineffective erythropoiesis 1. Cobalamin, folate, thalassemia, and severe iron deficiencies 3. Drugs 1. Rifampicin, probenecid, ribavirin 4. Inherited conditions 1. Crigler-Najjar types I and II 2. Gilbert's syndrome CAUSES OF ISOLATED HYPERBILIRUBINEMIA
  • 11. * • Complete absence of UDPGT activity • Reduced UDPGT activity CRIGGLER NAJAR syndrome type 1& 2 • Reduced UDPGT activity • Bilirubin 6mg/dL GILBERT syndrome
  • 12.
  • 13.
  • 14.
  • 15. *
  • 17. * • Mutation in gene for multiple drug resistance protein 2 Dubin johnson syndrome • Problem with hepatic storage of bilirubin Rotor syndrome
  • 19. * *Drugs. * H/o transfusions, intravenous and intranasal drug use ,tattoos and sexual activity. *H/o recent travel. *H/o exposure to people with jaundice . *H/o Exposure to contaminated foods. *H/o Alcohol consumption.
  • 20. *H/o myalgia , arthralgia ,rash. *Anorexia , weight loss *Abdominal pain *Fever *Pruritus *Changes in urine and stool colour.
  • 21. * *Arthralgia and myalgia precluding jaundice- HEPATITIS(viral or drug related). *Jaundice associated with sudden onset of severe RUQ pain and chills – CHOLEDOCHOLITHIASIS AND ASCENDING CHOLANGITIS.
  • 22. * *Temporal and Proximal muscle wasting – cirrhosis or pancreatic cancer. *Features of Chronic liver disease. *VIRCHOW’S NODE. *Sister Mary Joseph’s nodule. *ELEVATED JVP, ASCITES, RIGHT PLEURAL EFFUSION - CONGESTION
  • 23. * *Enlarged left lobe of liver – cirrhosis. *Nodular liver or abdominal mass- malignancy. *Enlarged tender liver- hepatitis viral or alcoholic , acutely congested liver. *Murphy’s sign- cholecystitis. *Ascites + jaundice – cirrhosis or malignancy.
  • 24. * *Patients with hepatocellular process- aminotransferases elevation disproportionate to ALP. *Patients with a cholestatic process have disproportionate elevation of ALP compared to aminotransferases.
  • 25.
  • 26. *SERUM ALBUMIN – A low serum albumin suggests a chronic process such as cirrhosis or cancer. *PROTHROMBIN TIME – elevated PT indicates either vitamin K deficiency due to prolonged jaundice or malabsorption or significant hepatocellular dysfunction.
  • 27. Viral hepatitis • Hepatitis A, B, C, D, and E • Epstein-Barr virus • Cytomegalovirus • Herpes simplex Alcohol Drug toxicity • Predictable, dose-dependent, (e.g., acetaminophen) • Unpredictable, idiosyncratic, (e.g., isoniazid) Environmental toxins • Vinyl chloride • Jamaica bush tea—pyrrolizidine alkaloids • Kava Kava • Wild mushrooms—Amanita phalloides or A. verna Wilson's disease Autoimmune hepatitis HEPATOCELLULAR CONDITIONS THAT MAY PRODUCE JAUNDICE
  • 28. * Viral hepatitis Alcohol DRUGS TOXINS Wilson’s disease/Autoimmune Hepatitis
  • 29. * *Patients with alcoholic hepatitis will have AST :ALT ratio of 2:1 *AST rarely exceeds 300 U/L. *Patients with hepatitis due to viral or toxin-related will have Aminotransferases > 500 U/L.
  • 30. * *IgM HAV. *Hbs Ag. *IgM anti Hbc. *HCV RNA. *Tests for EBV,CMV. *Wilson’s disease do Serum Ceruloplasmin level. *Autoimmune hepatitis – ANA and specific immunoglobulins.
  • 31. * *Intrahepatic *Extrahepatic *Do an USG that will detect the presence of biliary dilatation. *Biliary dilatation + = extrahepatic cholestasis *Biliary dilatation - = intrahepatic cholestasis
  • 32. * • Intrahepatic cholestasis • Primary biliary cirrhosis • Primary sclerosing cholangitis Extra hepatic cholestasis • Benign • Malignant
  • 33. 1.Intrahepatic 1. Viral hepatitis 1.Fibrosing cholestatic hepatitis—hepatitis B and C 2.Hepatitis A, Epstein-Barr virus, cytomegalovirus 2. Alcoholic hepatitis 3. Drug toxicity 1.Pure cholestasis—anabolic and contraceptive steroids 2.Cholestatic hepatitis—chlorpromazine, erythromycin estolate 3.Chronic cholestasis—chlorpromazine and prochlorperazine 4. Primary biliary cirrhosis 5. Primary sclerosing cholangitis 6. Vanishing bile duct syndrome 1.Chronic rejection of liver transplants 2.Sarcoidosis 3.Drugs CHOLESTATIC CONDITIONS THAT MAY PRODUCE JAUNDICE
  • 34. 1.Inherited 1.Progressive familial intrahepatic cholestasis 2.Benign recurrent cholestasis 2.Cholestasis of pregnancy 3.Total parenteral nutrition 4.Nonhepatobiliary sepsis 5.Benign postoperative cholestasis 6.Paraneoplastic syndrome 7.Venoocclusive disease 8.Graft-versus-host disease 9.Infiltrative disease 1.TB 2.Lymphoma 3.Amyloidosis
  • 35. * *Hepatitis B, Hepatitis C can cause a cholestatic hepatitis. *Hepatitis A , CMV, EBV, alcoholic hepatitis can also produce cholestatic picture. *Primary biliary cirrhosis –Antimitochondrial antibody. *Primary sclerosing cholangitis- multiple strictures of bile ducts with dilatation proximal to strictures.
  • 36. * *Distal CBD is an area that is difficult to be visualized by USG. *CT scan . *MRCP (Magnetic resonance cholangiography). *ERCP(Endoscopic Retrograde Cholangio Pancreatography).
  • 37. * *Benign and malignant cause. *Malignant causes include Pancreatic, Gall bladder , Ampullary and cholangiocarcinoma.
  • 38. *Extrahepatic *Malignant *Cholangiocarcinoma *Pancreatic cancer *Gallbladder cancer *Ampullary cancer *Malignant involvement of the porta hepatis lymph nodes *Benign *Choledocholithiasis *Postoperative biliary structures *Primary sclerosing cholangitis *Chronic pancreatitis *AIDS cholangiopathy *Mirizzi syndrome *Parasitic disease (ascariasis)
  • 40.
  • 42. *
  • 44. * Viral hepatitis Alcohol DRUGS TOXINS Wilson’s disease/Autoimmune Hepatitis
  • 45. * • Intrahepatic cholestasis • Primary biliary cirrhosis • Primary sclerosing cholangitis Extra hepatic cholestasis • Benign • Malignant
  • 46. * *Total bilirubin- 6.3mg/dl. *Direct bilirubin – 3.9 mg/dl. *Indirect bilirubin- 2.4 mg/dl.
  • 47. *SGOT – 292 U/L. *SGPT – 542 U/L. *ALP – 60 U/L.
  • 48. *TOTAL PROTEIN – 5.6 gm/dl. *Albumin – 3.7 gm/dl. *Globulin 1.9 gm/dl. *A/G ratio 1.9:1